Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) Gains from Investment Securities (2023 - 2025)

Historic Gains from Investment Securities for Tonix Pharmaceuticals Holding (TNXP) over the last 3 years, with Q3 2025 value amounting to $1.2 million.

  • Tonix Pharmaceuticals Holding's Gains from Investment Securities changed N/A to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year change of. This contributed to the annual value of $3865.0 for FY2024, which is 39935.4% up from last year.
  • Latest data reveals that Tonix Pharmaceuticals Holding reported Gains from Investment Securities of $1.2 million as of Q3 2025.
  • Tonix Pharmaceuticals Holding's 5-year Gains from Investment Securities high stood at $9.7 million for Q1 2024, and its period low was $774.0 during Q4 2023.
  • Moreover, its 3-year median value for Gains from Investment Securities was $1.2 million (2025), whereas its average is $2.7 million.
  • Examining YoY changes over the last 5 years, Tonix Pharmaceuticals Holding's Gains from Investment Securities showed a top increase of 27126.19% in 2025 and a maximum decrease of 9308.57% in 2025.
  • Tonix Pharmaceuticals Holding's Gains from Investment Securities (Quarter) stood at $774.0 in 2023, then soared by 40054.65% to $310797.0 in 2024, then surged by 272.54% to $1.2 million in 2025.
  • Its Gains from Investment Securities was $1.2 million in Q3 2025, compared to $1.2 million in Q2 2025 and $674134.0 in Q1 2025.